Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment
Clinical trial NCT04078178 · COMPLETED
Trial details
- NCT number
- NCT04078178
- Sponsor
- Steven E Arnold, MD
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2022-09-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.